Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Feb 24, 2022 6:55pm
406 Views
Post# 34459989

RE:RE:RE:Bidding war?

RE:RE:RE:Bidding war?beenthere, I have studied RMT, xB3, and the diseases that xB3-drugs might treat. A number of companies have made public deals with Bioasis. I have studied it all sufficiently to have confidence in what I write. Chiesi, Aposense, Oxyrane, Daiichi Sankyo and others implicitly confirm what I write. I speak the truth as I have studied and understand it.

You claim that Bioasis will not succeed. There is no other way to explain your behaviour. Despite your beliefs, you tell us that you hold "200k+" shares. If you are so smart, and if you believe that Bioasis, its partners and I are all lying, then how much intellectual horsepower can you claim to possess and still hold the stock despite your belief in its abject failure?

I won't post here what your problem is, beenthere, but every reader here understands what it is. Don't feel all alone and picked on, beenthere. You have company.

I will say this. I don't have much respect for whining cowards. You, Ftr, Aarcor and others are too boring and ignorant for my tastes. Any anonymous coward can call others names and spout the same old complaint every day. You're generally just light sport on slow days.

Don't drool on your keyboard, beenthere.
<< Previous
Bullboard Posts
Next >>